Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-15-000222
Filing Date
2015-03-30
Accepted
2015-03-30 16:55:27
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED 12/31/2014 appy_10k-123114.htm 10-K 955213
2 EXHIBIT 10.8 ex10x8.htm EX-10.8 5279
3 EXHIBIT 23 ex23.htm EX-23 2784
4 EXHIBIT 31.1 ex31x1.htm EX-31.1 12925
5 EXHIBIT 31.2 ex31x2.htm EX-31.2 12963
6 EXHIBIT 32 ex32.htm EX-32 7312
  Complete submission text file 0001079973-15-000222.txt   7749311

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT appy-20141231.xml EX-101.INS 1061679
8 XBRL TAXONOMY EXTENSION SCHEMA appy-20141231.xsd EX-101.SCH 37911
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20141231_cal.xml EX-101.CAL 51970
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20141231_def.xml EX-101.DEF 227770
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20141231_lab.xml EX-101.LAB 789421
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20141231_pre.xml EX-101.PRE 414490
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33675 | Film No.: 15735157
SIC: 2835 In Vitro & In Vivo Diagnostic Substances